Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Transplantation for Lupus Nephritis
NCT03458156Unknown
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Jan 2017
- Primary completion
- Sep 2019
- Modality
- Stem Cell Therapies
01
Overview
Open-label trial of human umbilical cord mesenchymal stem cells in systemic lupus erythematosus (SLE) and lupus nephritis (LN) (3 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: SLEDAI-2000 score at 12 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
systemic lupus erythematosus (SLE)lupus nephritis (LN)
Beyond the preview
Go deeper on NCT03458156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03458156.